Coxa Oy VA

Medicine & Life Sciences

1. Arthroplasty 100%
2. Hip 85%
3. Knee Replacement Arthroplasties 70%
4. Knee 39%
5. Finland 33%
6. Joints 27%
7. Metals 26%
8. Chondrocytes 23%
9. Patellar Dislocation 23%
10. Cobalt 22%
11. Osteoarthritis 22%
12. Confidence Intervals 21%
13. Incidence 20%
14. Chromium 20%
15. Infections 17%
16. Polyethylene 17%
17. Survival 15%
18. Knee Joint 14%
19. Tacrine 14%
20. Traumatic Brain Injury 11%
21. High-Volume Hospitals 11%
22. Hip Joint 10%
23. Reoperation 9%
24. Replacement Arthroplasties 9%
25. Cohort Studies 9%
26. Spinal Anesthesia 8%
27. RNA-Seq 8%
28. Pain 8%
29. Tibia 8%
30. melflufen 8%
31. Randomized Controlled Trials 8%
32. Head 7%
33. Ions 7%
34. Comorbidity 7%
35. Patella 7%
36. Periprosthetic Fractures 6%
37. Mesenchymal Stem Cells 6%
38. Dexamethasone 6%
39. Bone and Bones 6%
40. Patient Reported Outcome Measures 6%
41. Analgesics 6%
42. Propensity Score 6%
43. Neoprene 6%
44. Therapeutics 6%
45. Thigh 6%
46. Retrospective Studies 6%
47. Hallux Rigidus 6%
48. Knee Osteoarthritis 6%
49. Exercise 6%
50. Population 6%
51. Vitamin E 6%
52. Scandinavian and Nordic Countries 5%
53. Anti-Bacterial Agents 5%
54. Genes 5%
55. Articular Range of Motion 5%
56. Bone Marrow 5%
57. Wounds and Injuries 5%
58. Databases 5%
59. Osseointegration 5%
60. Craniotomy 5%
61. Phenotype 5%
62. Ankyrins 5%
63. Interleukin-1 5%
64. Ibuprofen 5%
65. Hallux Valgus 5%
66. Metatarsophalangeal Joint 5%
67. Thermometers 5%
68. Arthritis 5%
69. Osteolysis 5%
70. Debridement 5%
71. Femoral Fractures 5%
72. Prospective Studies 5%
73. Equivalence Trials 5%
74. Tendon Injuries 5%
75. compound A 12 5%